Latest News | Laurus Labs Signs Pact to Acquire Majority Stake in Richcore Lifesciences

Hyderabad, Nov 25 (PTI): Laurus Labs on Wednesday said it signed a definitive agreement to acquire a majority stake in Richcore Lifesciences Pvt Ltd, a Bengaluru-based biotech company.

Laurus Labs has signed a definitive agreement to acquire 72.55 per cent of Richcore's shares from Eight Roads Ventures and VenturEast for Rs 246.7 crore, a press release from the city-based drug maker saidsaid.

Also Read | Vivo V20 Pro Smartphone Teased Online Ahead of India Launch.

The current promoters of Richcore, led by Subramani Ramachandrappa, will continue as promoters and will be responsible for its management and operations.

Laurus Labs will fund the acquisition from its internal accruals and this acquisition will be revenue and profit accretive, the release added.

Also Read | Google Pay Clarifies No Money Transfer Fee to Be Charged for Indian Users.

Richcore has advanced Research and Development and manufacturing facilities and develops and manufactures biotech products.

It also helps its global customers develop and scale-up their bioprocesses by providing contract research, development and manufacturing services.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)